- Filed
- Aug 26, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Aug 21, 2025 | 13.32M sh |
| Shares Diluted | FY 2025 · Mar 31, 2025 | 5.15M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 4.91M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 4.83M sh |
| Shares Diluted restated | FY 2025 · Mar 31, 2024 | 4.75M sh |
| Capex | FY 2025 · Mar 31, 2025 | $4.95M |
| Capex | FY 2025 · Dec 31, 2024 | $4.32M |
| Capex | FY 2025 · Mar 31, 2024 | $5.87M |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | −$23.61M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$20.35M |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | −$10.16M |
| Cash And Equivalents | FY 2025 · Mar 31, 2025 | $16.46M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $20.38M |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $25.69M |
| Stockholders Equity | FY 2025 · Mar 31, 2025 | −$164.37M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$196.62M |
| Stockholders Equity | FY 2025 · Sep 30, 2024 | −$151.1M |
| Stockholders Equity | FY 2025 · Mar 31, 2024 | −$121.5M |
| Stockholders Equity restated | FY 2025 · Mar 31, 2023 | −$84.37M |
| Current Liabilities | FY 2025 · Mar 31, 2025 | $257.61M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $302.39M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $249.94M |
| Total Liabilities | FY 2025 · Mar 31, 2025 | $319.77M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $364.68M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $309.11M |
| Current Assets | FY 2025 · Mar 31, 2025 | $102.81M |
| Current Assets | FY 2025 · Dec 31, 2024 | $113.83M |
| Current Assets | FY 2025 · Mar 31, 2024 | $131.78M |
| Total Assets | FY 2025 · Mar 31, 2025 | $155.4M |
| Total Assets | FY 2025 · Dec 31, 2024 | $168.06M |
| Total Assets | FY 2025 · Mar 31, 2024 | $187.62M |
| Eps Diluted | FY 2025 · Mar 31, 2025 | −$22.35 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$15.35 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$22.22 |
| Eps Diluted restated | FY 2025 · Mar 31, 2024 | −$8.68 |
| Eps Basic | FY 2025 · Mar 31, 2025 | −$22.35 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$15.35 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$22.22 |
| Eps Basic restated | FY 2025 · Mar 31, 2024 | −$8.68 |
| Sga Expense | FY 2025 · Mar 31, 2025 | $63.96M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $14.14M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $49.19M |
| Sga Expense | FY 2025 · Mar 31, 2024 | $51.55M |
| Rd Expense | FY 2025 · Mar 31, 2025 | $31.14M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $7.68M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $24.26M |
| Rd Expense | FY 2025 · Mar 31, 2024 | $38.05M |
| Net Income | FY 2025 · Mar 31, 2025 | −$115.09M |
| Net Income | FY 2025 · Dec 31, 2024 | −$75.3M |
| Net Income | FY 2025 · Dec 31, 2024 | −$107.35M |
| Net Income | FY 2025 · Mar 31, 2024 | −$41.29M |
| Operating Income | FY 2025 · Mar 31, 2025 | −$41.68M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$7.73M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$30.09M |
| Operating Income | FY 2025 · Mar 31, 2024 | −$28.88M |
| Gross Profit | FY 2025 · Mar 31, 2025 | $109.83M |
| Gross Profit | FY 2025 · Dec 31, 2024 | $27.89M |
| Gross Profit | FY 2025 · Dec 31, 2024 | $85.59M |
| Gross Profit | FY 2025 · Mar 31, 2024 | $124.89M |
| Revenue | FY 2025 · Mar 31, 2025 | $274.06M |
| Revenue | FY 2025 · Dec 31, 2024 | $68.68M |
| Revenue | FY 2025 · Dec 31, 2024 | $212.8M |
| Revenue | FY 2025 · Mar 31, 2024 | $311.6M |